 Pharmaceutical logistics is not simply the purchase, sale, storage or distribution of drugs. The so-called medical logistics refers to: relying on certain logistics equipment, technology and logistics management information system, effectively integrating upstream and downstream resources of marketing channels, improving order processing capability, reducing goods sorting errors, shortening inventory and distribution time, and reducing logistics costs by optimizing the acceptance, storage, sorting, distribution and other operating processes in the drug supply, marketing, and distribution links, Improve service level and fund utilization efficiency, and realize automation, informatization and efficiency.
At present, China's pharmaceutical logistics is in the initial stage of development, and a lot of things have been done“ Pharmaceutical Logistics” People have not yet figured out what logistics is. This shows that people still have some misunderstandings about pharmaceutical logistics from the perspective of investment or management. Current situation of domestic pharmaceutical logistics
Looking at the development process of China's pharmaceutical logistics industry, China's pharmaceutical logistics industry is still in its infancy and not yet mature; One characteristic, two trends, three misunderstandings and four problems” To summarize: At present, the biggest characteristic of China's pharmaceutical logistics industry is that it is still in the stage of single link optimization of the supply chain. China's pharmaceutical logistics started relatively late. At present, most of the pharmaceutical logistics projects that have been launched or are about to be launched are still at the stage of internal business integration of purchase, sales and storage, and process optimization, rarely involving the integration of upstream pharmaceutical manufacturers, suppliers, downstream pharmaceutical wholesale and retail enterprises, and hospitals, which can not fundamentally solve the problem of repeated transportation, bullwhip effect The phenomenon of overstock has led to a series of syndromes such as low efficiency of the supply chain, increased drug distribution costs, and unreasonable drug prices. Two trends: In the future, there are two significant trends in China's pharmaceutical logistics industry: first, logistics integration has risen to the height of enterprise strategic management; The second is to separate logistics service from main business and implement professional management. Three misunderstandings: (1) SMEs are unnecessary and unable to integrate logistics (2) Equipment and technology determine competitiveness (3) Automation brings cost reduction Four problems: (1) The supporting policies and standards are not in place; (2) The investment is overheated and scattered, and there is a lack of effective integration; (3) The third-party logistics is immature; (4) There is a lack of professional management personnel For the analysis of the development trend of the pharmaceutical logistics industry, the Chinese Academy of Mechanical Engineering believes that:“ After decades of development, China's pharmaceutical industry has developed faster than the global average and higher than the national average industrial growth rate. The rapid growth of the pharmaceutical industry has led to the rapid development of the pharmaceutical logistics industry. Guided by market demand and supported by national policies, a number of powerful state-owned or private pharmaceutical enterprises have vigorously developed pharmaceutical logistics and e-commerce. In addition, the market penetration of the third-party medical logistics in China is at a low level, but with a large amount of funds beginning to be active in the field of medical logistics, the third-party logistics providing professional logistics services is bound to become a new economic growth point.
With the rapid development of China's economy, the improvement of people's living standards, the implementation of the basic medical insurance system, and the implementation of drug classification management, people's demand for medicine will continue to increase, and the pharmaceutical retail industry and pharmaceutical logistics industry have also developed rapidly. By the end of 2008, there were 13000 pharmaceutical logistics enterprises in China, and the industry was characterized by many, small, scattered and disordered industries. The three pharmaceutical logistics enterprises, Sinopharm, Shanghai Pharmaceutical and Jiuzhoutong, currently rank among the top three in the industry, but their share in the whole industry is less than 20%.
In the context of medical reform, since the end of 2009, the integration of the pharmaceutical logistics industry has been accelerating. Domestic pharmaceutical logistics giants have built new pharmaceutical logistics centers in various places, or implemented large-scale mergers and acquisitions. At present, the domestic pharmaceutical logistics industry is still in the extension development stage of expanding scale. Only by entering the connotation development stage with technology and management as the starting point as soon as possible, can the pharmaceutical logistics industry continue to develop healthily.
The prospect of China's pharmaceutical market is bright. The fundamental reason for the high price of drugs in China is that there are too many intermediate links. The introduction of modern logistics will quickly, efficiently and cheaply create a rich“ Third party profit”. Therefore, China's pharmaceutical logistics market has great potential for development. Although the development prospect of pharmaceutical logistics in China is promising, and relevant policies have also given support, enterprises still need to conduct in-depth research when carrying out or investing in the construction of pharmaceutical logistics, fully consider the entry opportunity, market demand, investment returns and other aspects, and prevent the reckless behavior of blindly following the trend& rdquo;
|
